Lee, Wonwoo
Min, In Kyung
Yang, Kwang Ik
Kim, Daeyoung
Yun, Chang-Ho
Chu, Min Kyung
Funding for this research was provided by:
National Research Foundation of Korea (2019R1F1A1053841)
Article History
Received: 20 June 2021
Accepted: 25 October 2021
First Online: 3 November 2021
Competing interests
: M.K.C. was a site investigator for a multicenter trial sponsored by Otsuka Korea, Novartis, International AG and Eli Lilly and Co. He also worked as an advisory member for Teva and has received lecture honoraria from Allergan Korea, Handok-Teva and Yuyu Pharmaceutical Company in the past 24 months. Further, he received grants from the Yonsei University College of Medicine (2018-32-0037) and National Research Foundation of Korea (2019R1F1A1053841). The other authors have no potential conflicts of interest to disclose.